Profissionais de Saúde

Profissionais de Saúde

Referências Bibliográficas

Célula Tronco

1. StemBook [Internet]. Cambridge (MA): Harvard Stem Cell Institute; 2008-. Available from:
http://www.ncbi.nlm.nih.gov/books/NBK27044/

2. Non-haematological uses of cord blood stem cells.
Harris DT.
Br J Haematol. 2009 Oct;147(2):177-84. Review.

3. Cell therapy using induced pluripotent stem cells or somatic stem cells: this is the question.
Somoza RA, Rubio FJ.
Curr Stem Cell Res Ther. 2012 May;7(3):191-6.

4. Adult mesenchymal stem cells
Schipani, E. and Kronenberg, H.M.
StemBook, ed. (January 31, 2009) The Stem Cell Research Community, StemBook
doi/10.3824/stembook.1.38.1, http://www.stembook.org.

5. Cord blood hematopoietic stem cell transplantation
Broxmeyer, H.E.
StemBook, ed. (May 26, 2010) The Stem Cell Research Community, StemBook,
doi/10.3824/stembook.1.52.1, http://www.stembook.org.

6. Non-haematological uses of cord blood stem cells.
Harris DT.
Br J Haematol. 2009 Oct;147(2):177-84. Review.

7. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers.
La Rocca G, Anzalone R, Corrao S, Magno F, Loria T, Lo Iacono M, Di Stefano A, Giannuzzi P, Marasà L, Cappello F, Zummo G, Farina F.
Histochem Cell Biol. 2009 Feb;131(2):267-82. Epub 2008 Oct 3.

8. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.
Kern S, Eichler H, Stoeve J, Klüter H, Bieback K.
Stem Cells. 2006 May;24(5):1294-301. Epub 2006 Jan 12.

9. Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos.
Wang XY, Lan Y, He WY, Zhang L, Yao HY, Hou CM, Tong Y, Liu YL, Yang G, Liu XD, Yang X, Liu B, Mao N.
Blood. 2008 Feb 15;111(4):2436-43. Epub 2007 Nov 28.

10. Cord blood hematopoietic stem cell transplantation
Broxmeyer, H.E. StemBook, ed. (May 26, 2010) The Stem Cell Research Community, StemBook,
doi/10.3824/stembook.1.52.1, http://www.stembook.org.

11. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling.
Gluckman E, Broxmeyer H.A, Auerbach A.D, Friedman H.S, Douglas G.W, Devergie A, Esperou H, Thierry D, Socie G, Lehn P, et al. N
Engl J Med. 1989;321:1174–1178

12. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S.
Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM.
Biol Blood Marrow Transplant. 2008 Mar;14(3):316-22.

13. http://www.cibmtr.org

14. www.clinicaltrials.gov

15. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E.
N Engl J Med. 2000 Jun 22;342(25):1846-54.

16. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.
Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, Jacobsen N, Ruutu T, de Lima M, Finke J, Frassoni F, Gluckman E; Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry.
N Engl J Med. 2004 Nov 25;351(22):2276-85.

17. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.
Barker JN, Davies SM, DeFor T, Ramsay NK, Weisdorf DJ, Wagner JE.
Blood. 2001 May 15;97(10):2957-61.

18. Patents versus transplants.
Gluckman E, O'Reilly R, Wagner J, Rubinstein P.
Nature. 1996 Jul 11;382(6587):108.

19. Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells.
Bieback K, Schallmoser K, Klüter H, Strunk D.
Transfus Med Hemother. 2008;35(4):286-294.

20. New Approaches for Improving Engraftment after Cord Blood Transplantation.
Rocha V, Broxmeyer H.E.
Biol Blood Marrow Transplant. 2010;16:S126–S132.

21. Umbilical cord blood: information for childbirth educators.
Waller-Wise R.
J Perinat Educ. 2011 Winter;20(1):54-60.

22. Mesenchymal stem cells: Molecular characteristics and clinical applications.
Rastegar F, Shenaq D, Huang J, Zhang W, Zhang BQ, He BC, Chen L, Zuo GW, Luo Q, Shi Q, Wagner ER, Huang E, Gao Y, Gao JL, Kim SH, Zhou JZ, Bi Y, Su Y, Zhu G, Luo J, Luo X, Qin J, Reid RR, Luu HH, Haydon RC, Deng ZL, He TC.
World J Stem Cells. 2010 Aug 26;2(4):67-80.

23. Clinical trials for stem cell therapies.
Trounson A, Thakar RG, Lomax G, Gibbons D.
BMC Med. 2011 May 10;9:52. Review.

24. Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives.
Dalous J, Larghero J, Baud O.
Pediatr Res. 2012 Apr;71(4 Pt 2):482-90.

25. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.
Friedman R, Betancur M, Boissel L, Tuncer H, Cetrulo C, Klingemann H.
Biol Blood Marrow Transplant. 2007 Dec;13(12):1477-86.

26. www.clinicaltrials.gov

27. Wharton's Jelly stem cells: future clinical applications.
Taghizadeh RR, Cetrulo KJ, Cetrulo CL.
Placenta. 2011 Oct;32 Suppl 4:S311-5. Epub 2011 Jul 6. Review.

28. Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment.
Anjos-Afonso F, Bonnet D. Blood.
2007;109:1298–1306.

29. Umbilical cord blood: information for childbirth educators.
Waller-Wise R. J Perinat
Educ. 2011 Winter;20(1):54-60.

30. StemBook [Internet]. Cambridge (MA): Harvard Stem Cell Institute; 2008-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK27044/

31. Immunogenetics of allogeneic HSCT. The role of HLA in HSCT
J.M. Tiercy ESH-EBMT Handbook on Haematopoietic Stem Cell Transplantation (Jun, 2008), 46-65
J. Apperley, E. Carreras, E. Gluckman, A. Gratwohl, T. Masszi http://www.ebmt.org/Contents/Resources/Library/EBMTESHhandbook/Documents/EBMT2008_Cap3_1.pdf

32. New Approaches for Improving Engraftment after Cord Blood Transplantation.
Rocha V, Broxmeyer H.E.
Biol Blood Marrow Transplant. 2010;16:S126–S132.

33. www.clinicaltrials.gov

Perguntas Frequentes

1. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S.
Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM.
Biol Blood Marrow Transplant. 2008 Mar;14(3):316-22.

2. Non-haematological uses of cord blood stem cells.
Harris DT.
Br J Haematol. 2009 Oct;147(2):177-84. Review.

3. The probability of finding a suitable related donor for bone marrow transplantation in extended families.
Schipper RF, D'Amaro J, Oudshoorn M.
Blood. 1996 Jan 15;87(2):800-4.

4. Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program
Institute of Medicine (U.S.). Committee on Establishing a National Cord Blood Stem Cell Bank Program, Emily Ann Meyer, Kathi E. Hanna, Kristine M. Gebbie
The National Academy Press, 2005

5. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys.
Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, Tukun A, Uckan D, Can A.
Stem Cells. 2007 Feb;25(2):319-31. Epub 2006 Oct 19.

6. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord.
Romanov YA, Svintsitskaya VA, Smirnov VN.
Stem Cells. 2003;21(1):105-10.

7. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.
Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC.
Stem Cells. 2004;22(7):1330-7.

8. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors.
Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE.
Stem Cells. 2005 Feb;23(2):220-9.

9. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells.
Can A, Karahuseyinoglu S.
Stem Cells. 2007 Nov;25(11):2886-95. Epub 2007 Aug 9. Review.

10. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.
Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID.
Nat Med. 2010 Feb;16(2):232-6. Epub 2010 Jan 17.

11. Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.
Broxmeyer HE, Lee MR, Hangoc G, Cooper S, Prasain N, Kim YJ, Mallett C, Ye Z, Witting S, Cornetta K, Cheng L, Yoder MC.
Blood. 2011 May 5;117(18):4773-7. Epub 2011 Mar 10.

12. Mesenchymal stem cells in health and disease.
Uccelli A, Moretta L, Pistoia V.
Nat Rev Immunol. 2008 Sep;8(9):726-36. Review.

13. Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms.
Prockop DJ.
Mol Ther. 2009 Jun;17(6):939-46. Epub 2009 Mar 31. Review.

14. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E.
Cytotherapy. 2006;8(4):315-7.

15. Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys.
Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, Tukun A, Uckan D, Can A.
Stem Cells. 2007 Feb;25(2):319-31. Epub 2006 Oct 19.

16. Characterization of mesenchymal stromal cells derived from full-term umbilical cord blood.
Manca MF, Zwart I, Beo J, Palasingham R, Jen LS, Navarrete R, Girdlestone J, Navarrete CV.
Cytotherapy. 2008;10(1):54-68.

17. Multipotent mesenchymal stromal cells and the innate immune system.
Le Blanc K, Mougiakakos D.
Nat Rev Immunol. 2012 Apr 25;12(5):383-96.

18. Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos.
Wang XY, Lan Y, He WY, Zhang L, Yao HY, Hou CM, Tong Y, Liu YL, Yang G, Liu XD, Yang X, Liu B, Mao N.
Blood. 2008 Feb 15;111(4):2436-43. Epub 2007 Nov 28.

19. Wharton's jelly-derived cells are a primitive stromal cell population.
Troyer DL, Weiss ML.
Stem Cells. 2008 Mar;26(3):591-9. Epub 2007 Dec 6. Review.

20. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers.
La Rocca G, Anzalone R, Corrao S, Magno F, Loria T, Lo Iacono M, Di Stefano A, Giannuzzi P, Marasà L, Cappello F, Zummo G, Farina F.
Histochem Cell Biol. 2009 Feb;131(2):267-82. Epub 2008 Oct 3.

21. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.
Kern S, Eichler H, Stoeve J, Klüter H, Bieback K.
Stem Cells. 2006 May;24(5):1294-301. Epub 2006 Jan 12.

Porque Armazenar

1. Clinical trials for stem cell therapies.
Trounson A, Thakar RG, Lomax G, Gibbons D.
BMC Med. 2011 May 10;9:52. Review.

2. Adult mesenchymal stem cells.
Schipani, E. and Kronenberg, H.M.

3. StemBook, ed. (January 31, 2009)
The Stem Cell Research Community, StemBook, doi/10.3824/stembook.1.38.1,
http://www.stembook.org

4. Cord blood hematopoietic stem cell transplantation.
Broxmeyer, H.E. StemBook, ed. (May 26, 2010) The Stem Cell Research Community, StemBook, doi/10.3824/stembook.1.52.1,
http://www.stembook.org

5. Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.
Broxmeyer HE, Lee MR, Hangoc G, Cooper S, Prasain N, Kim YJ, Mallett C, Ye Z, Witting S, Cornetta K, Cheng L, Yoder
MC. Blood. 2011 May 5;117(18):4773-7.

6. A simple and reliable procedure for cord blood banking, processing, and freezing: St Louis and Ohio Cord Blood Bank experiences.
Alonso JM 3rd, Regan DM, Johnson CE, Oliver DA, Fegan R, Lasky LC, Wall DA.
Cytotherapy. 2001;3(6):429-33.

7. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.
Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, Taylor PE, Stevens CE. Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program Institute of Medicine (U.S.). Committee on Establishing a National Cord Blood Stem Cell Bank Program Emily Ann Meyer, Kathi E. Hanna, Kristine M. Gebbie
The National Academy Press, 2005.

8. Cord Blood Hematopoietic Cell Transplantation.
Broxmeyer, H.E. Smith, F.O
Thomas’ Hematopoietic Cell Transplantation (2009) 4th Edition. Appelbaum, F.R. Forman, S.J. Negrin, R.S. Blume, K.G. West Sussex, United Kingdom: Wiley-Blackwell; , 559–576

9. Umbilical cord transplantation: epilogue.
Broxmeyer HE. Semin Hematol. 2010 Jan;47(1):97-103.

10. Non-haematological uses of cord blood stem cells.
Harris DT.
Br J Haematol. 2009 Oct;147(2):177-84. Review.

11. Dados apresentados no congresso da SBTMO em agosto/2012.

12. Dados informados pelos 3 maiores bancos de cordão umbilical fora do Brasil
http://www.cordblood.com/en/best-cord-blood-bank/~/media/Files/FAQs/transplant_summary.pdf http://www.viacord.com/Collateral/Documents/Common/Transplant%20Summaries/TxSummary240.pdf
http://www.cryo-cell.com/cord-blood/banking-benefits/transplant-matrix

13. Mesenchymal stem cells: Molecular characteristics and clinical applications.
Rastegar F, Shenaq D, Huang J, Zhang W, Zhang BQ, He BC, Chen L, Zuo GW, Luo Q, Shi Q, Wagner ER, Huang E, Gao Y, Gao JL, Kim SH, Zhou JZ, Bi Y, Su Y, Zhu G, Luo J, Luo X, Qin J, Reid RR, Luu HH, Haydon RC, Deng ZL, He TC.
World J Stem Cells. 2010 Aug 26;2(4):67-80.

14. Clinical trials for stem cell therapies.
Trounson A, Thakar RG, Lomax G, Gibbons D.
BMC Med. 2011 May 10;9:52. Review.

15. Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives.
Dalous J, Larghero J, Baud O.
Pediatr Res. 2012 Apr;71(4 Pt 2):482-90.

16. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.
Friedman R, Betancur M, Boissel L, Tuncer H, Cetrulo C, Klingemann H.
Biol Blood Marrow Transplant. 2007 De<pc;13(12):1477-86.

Perguntas Frequentes

22. Cryopreservation of Human Stem Cells for Clinical Application: A Review.
Hunt CJ.
Transfus Med Hemother. 2011;38(2):107-123. Epub 2011 Mar 16.

23. Umbilical cord blood: information for childbirth educators.
Waller-Wise R.
J Perinat Educ. 2011 Winter;20(1):54-60.

24. Bone marrow donors worldwide annual report 2010

25. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Rocha V, Wagner JE Jr, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM, Gluckman E.
N Engl J Med. 2000 Jun 22;342(25):1846-54.

26. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.
Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, Jacobsen N, Ruutu T, de Lima M, Finke J, Frassoni F, Gluckman E; Acute Leukemia Working Party of European Blood and Marrow Transplant Group; Eurocord-Netcord Registry.
N Engl J Med. 2004 Nov 25;351(22):2276-85.

27. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.
Barker JN, Davies SM, DeFor T, Ramsay NK, Weisdorf DJ, Wagner JE.
Blood. 2001 May 15;97(10):2957-61.

28. Patents versus transplants.
Gluckman E, O'Reilly R, Wagner J, Rubinstein P.
Nature. 1996 Jul 11;382(6587):108.

29. Mesenchymal stem cells: Molecular characteristics and clinical applications.
Rastegar F, Shenaq D, Huang J, Zhang W, Zhang BQ, He BC, Chen L, Zuo GW, Luo Q, Shi Q, Wagner ER, Huang E, Gao Y, Gao JL, Kim SH, Zhou JZ, Bi Y, Su Y, Zhu G, Luo J, Luo X, Qin J, Reid RR, Luu HH, Haydon RC, Deng ZL, He TC.
World J Stem Cells. 2010 Aug 26;2(4):67-80.

30. Clinical trials for stem cell therapies.
Trounson A, Thakar RG, Lomax G, Gibbons D.
BMC Med. 2011 May 10;9:52. Review.

31. Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives.
Dalous J, Larghero J, Baud O.
Pediatr Res. 2012 Apr;71(4 Pt 2):482-90.

32. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.
Friedman R, Betancur M, Boissel L, Tuncer H, Cetrulo C, Klingemann H.
Biol Blood Marrow Transplant. 2007 Dec;13(12):1477-86.

33. Mesenchymal stromal cells: a novel and effective strategy for facilitating engraftment and accelerating hematopoietic recovery after transplantation?
Bernardo ME, Cometa AM, Locatelli F.

34. Wharton's Jelly stem cells: future clinical applications.
Taghizadeh RR, Cetrulo KJ, Cetrulo CL.
Placenta. 2011 Oct;32 Suppl 4:S311-5. Epub 2011 Jul 6. Review.

35. www.clinicaltrials.gov

36. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue.
Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, Bae YC, Jung JS.
Cell Physiol Biochem. 2004;14(4-6):311-24.

37. Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.
Anzalone R, Lo Iacono M, Loria T, Di Stefano A, Giannuzzi P, Farina F, La Rocca G.
Stem Cell Rev. 2011 Jun;7(2):342-63. Review.

38. A simple and reliable procedure for cord blood banking, processing, and freezing: St Louis and Ohio Cord Blood Bank experiences.
Alonso JM 3rd, Regan DM, Johnson CE, Oliver DA, Fegan R, Lasky LC, Wall DA.
Cytotherapy. 2001;3(6):429-33.

39. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.
Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, Taylor PE, Stevens CE.

40. RESOLUÇÃO - RDC N 56, DE 16 DE DEZEMBRO DE 2010.
www.anvisa.gov.br/legis/index.htm

41. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM.
N Engl J Med. 2004 Nov 25;351(22):2265-75.

42. Advances in graft-versus-host disease biology and therapy.
Blazar BR, Murphy WJ, Abedi M.
Nat Rev Immunol. 2012 May 11;12(6):443-58

43. Cystic fibrosis.
Rowe SM, Miller S, Sorscher EJ.
N Engl J Med. 2005 May 12;352(19):1992-2001.

44. Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells.
Bieback K, Schallmoser K, Klüter H, Strunk D.
Transfus Med Hemother. 2008;35(4):286-294.

Planos & Serviços

1. Cord Blood Hematopoietic Cell Transplantation.
Broxmeyer, H.E. Smith, F.O
Thoma's Hematopoietic Cell Transplantation (2009) 4th Edition. Appelbaum, F.R. Forman, S.J. Negrin, R.S. Blume, K.G. West Sussex, United Kingdom: Wiley-Blackwell; , 559–576

2. Umbilical cord transplantation: epilogue.
Broxmeyer HE.
Semin Hematol. 2010 Jan;47(1):97-103.

3. Non-haematological uses of cord blood stem cells.
Harris DT.
Br J Haematol. 2009 Oct;147(2):177-84. Review.

4. www.clinicaltrails.gov

5. RESOLUÇÃO - RDC N 56, DE 16 DE DEZEMBRO DE 2010.
www.anvisa.gov.br/legis/index.htm

6. Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program
Institute of Medicine (U.S.). Committee on Establishing a National Cord Blood Stem Cell Bank Program,
Emily Ann Meyer, Kathi E. Hanna, Kristine M. Gebbie
The National Academy Press, 2005

7. Lifetime probabilities of hematopoietic stem cell transplantation in the U.S.
Nietfeld JJ, Pasquini MC, Logan BR, Verter F, Horowitz MM.
Biol Blood Marrow Transplant. 2008 Mar;14(3):316-22.

8. Mesenchymal stem cells: Molecular characteristics and clinical applications
Rastegar F, Shenaq D, Huang J, Zhang W, Zhang BQ, He BC, Chen L, Zuo GW, Luo Q, Shi Q, Wagner ER, Huang E, Gao Y, Gao JL, Kim SH, Zhou JZ, Bi Y, Su Y, Zhu G, Luo J, Luo X, Qin J, Reid RR, Luu HH, Haydon RC, Deng ZL, He TC.
World J Stem Cells. 2010 Aug 26;2(4):67-80.

9. Clinical trials for stem cell therapies.
Trounson A, Thakar RG, Lomax G, Gibbons D.
BMC Med. 2011 May 10;9:52. Review.

10. Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives.
Dalous J, Larghero J, Baud O.
Pediatr Res. 2012 Apr;71(4 Pt 2):482-90.

11. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.
Friedman R, Betancur M, Boissel L, Tuncer H, Cetrulo C, Klingemann H.
Biol Blood Marrow Transplant. 2007 Dec;13(12):1477-86.

12. www.clinicaltrials.gov

Contato

0800 707 2673 Atendimento
(horário comercial)

0800 888 2673
Hotline de coletas (24/7)

Rua Alvarenga 2226
Butantã - São Paulo,
SP - 05509-006

Curta a CordVida

 


Siga a CordVida

videos flat 100x100
Vídeos CordVida


accredited
Todos os processos da CordVida estão de acordo com os melhores padrões mundiais certificados pela AABB (American Association of Blood Banks)